ArticleBMC psychology2026
"Is a general belief in one's capabilities related to mental and physical health?": The relationships between self-efficacy, health outcomes, and health-related behaviour.
Article in BMC psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSelf-efficacy, reflecting an individual’s belief in their ability to achieve goals, influences motivation, behaviour, and success. Understanding the interrelationships between general self-efficacy (GSE) and chronic conditions can contribute to developing prevention and treatment strategies.
methodsWe surveyed 3,532 participants (age = 31.73 ± 13.13 years, 66% females) using an online questionnaire that assessed GSE, chronic conditions, health complaints, and health-related behaviours. Binary logistic regression analysed associations.
resultsHigher GSE levels were associated with reduced odds of several chronic conditions, including pain of unclear origin (4%, 95% CI [0–8], p < 0.05), anxiety (6%, 95% CI [4–9], p < 0.001), and depression (5%, 95% CI [2–8], p < 0.01). Furthermore, higher GSE levels were associated with a 10% (95% CI [9, 12], p < 0.001) reduction in the odds of nervousness, an 8% (95% CI [6–10], p < 0.001) reduction in the odds of heart pounding/chest pain, and a 7% reduction in the odds of depressive feelings (95% CI [6–8], p < 0.001) and irritability/bad mood (95% CI [6–9], p < 0.001). Overall, negative associations were found with all tested health complaints except for intestinal complaints. Conversely, higher GSE levels were associated with increased odds of asthma (3%, 95% CI [0–5], p < 0.05) and coffee consumption (2%, 95% CI [1–4], p < 0.001).
conclusionGSE was moderately associated with health complaints, chronic conditions, and health-related behaviours, suggesting its importance in the prevention and management of chronic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.